A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Taiwan University, National Taiwan University Hospital, Siriraj Hospital, Samsung Medical Center, Asan Medical Center, University of Ulsan, Taipei Veterans General Hospital, National Yang Ming University, Chinese University of Hong Kong, Eli Lilly (India), Lilly (China), Sungkyunkwan University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2486120169